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Background: Avoiding cardiopulmonary bypass in coronary artery bypass grafting
is thought to reduce early mortality and morbidity.
Methods: We used our prospective database to compare all patients having off-
pump coronary surgery (n  389) with those having on-pump coronary surgery
(n 2412) between March 15, 1995, and November 1, 2000. Patients were grouped
by age (years) in decades (90, 80-89, 70-79, 60-69, 60 years). The Northern
New England risk model was applied. Thirty-two independent variables were
entered into a stepwise logistic regression analysis with the end points being surgical
mortality and postoperative stroke.
Results: Patients undergoing off-pump operations were older (70.9  12 vs 68.1 
11 years; P  .001), and their Northern New England predicted risk was higher
(11.9%  13% vs 9.2%  10%; P  .001). However, patients having on-pump
bypass had significantly more bypass grafts constructed (3.3  0.8 vs 1.9  0.8; P
 .001) and triple-vessel coronary artery disease (58% vs 28%; P  .001). There
were no significant differences in postoperative mortality, stroke rate, complica-
tions, and length of stay between the groups. Logistic regression analysis did not
show that cardiopulmonary bypass was a risk factor for either surgical mortality
(odds ratio, 1.08; P  .83) or stroke (odds ratio, 1.59; P  .27).
Conclusion: Off-pump coronary bypass did not reduce early mortality and morbid-
ity. Early and late results should be compared in a prospective randomized study.
Beating-heart surgery was originally the only approach to myocar-dial revascularization.1 In 1967, Kolessov2 reported a left internalthoracic artery (LITA) to left anterior descending (LAD) coronaryartery anastomosis through a left thoracotomy on a beating heart, asa method of treatment for angina pectoris. However, this wasquickly abandoned in favor of coronary artery bypass grafting
(CABG) via median sternotomy with modern cardiopulmonary bypass (CPB) tech-
niques because of the improved safety and ease of suturing on a still, bloodless field.
Off-pump coronary surgery (OPCAB) has been reintroduced in the past few
years and now accounts for nearly 20% of all CABG operations performed in the
United States.1 This is despite the lack of prospective randomized studies docu-
menting proven mortality or morbidity benefits in the short or long term.
Cardiac surgeons endure less favorable operative exposure, safety, and a steep
learning curve to perform arterial bypass grafting on a “beating” heart because of the
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belief that avoiding CPB improves end organ function by
diminishing microembolic activation of inflammatory cas-
cades and mechanical trauma to blood elements.
Patients and Methods
Between March 15, 1995, and November 1, 2000, 2801 patients
had isolated CABG with 389 patients having OPCAB, 368 via a
median sternotomy and 21 through a small anterior thoracotomy.
Another 2412 patients had on-pump CABG. All patients’ data
were entered into our cardiac surgical database, which follows 576
preoperative, intraoperative, and postoperative variables. Patients
were grouped by age (years) in decades (90, 80-89, 70-79,
60-69, and 60 years). The Northern New England (NNE) risk
model was used to predict surgical mortality.3
Statistical Analysis
Results for continuous variables are expressed as mean standard
deviation. Results for categorical variables are expressed as num-
ber (percent). The Student t test for independent samples was used
to determine statistically significant differences between the 2
groups for the continuous variables. The 2 test was used to
determine statistically significant group differences for the cate-
gorical variables. Stepwise logistic regression was used to select
the predictor variables for the outcomes surgical mortality and
postoperative cerebrovascular accident (CVA). (See the appendix
for the list of potential predictor variables that were considered).
The final logistic regression models included only those variables
that were significant in the stepwise logistic regression models. In
the final models, the independent variables are expressed as odds
ratios with 95% confidence intervals, and the corresponding P
value is also given. An  level of .05 was used to determine
statistical significance. Statistical calculations were performed by
means of SAS version 8.1 (SAS Institute, Cary, NC).
Incomplete revascularization was derived by comparing signif-
icantly obstructed coronary arteries at cardiac catheterization with
coronary arteries surgically grafted. Nongrafting of any signifi-
cantly obstructed coronary artery was considered an incomplete
revascularization. Grafting of all diseased vessels was considered
complete revascularization.
Learning Curve
All operations involved 2 surgeons, as surgeon and first assistant
surgeon, who performed the proximal and distal anastomoses. The
6 surgeons, present during the entire period of the study, partici-
pated in a minimum of 95 to a maximum of 149 cases. There was
a gradual adoption of off-pump techniques with 3.5% of OPCABs
performed in 1996, 9% in 1997, 15.2% in 1998, 28.1% in 1999,
and 26.4% in 2000.
Patient Selection
The choice of OPCAB versus on-pump CABG was surgeon pref-
erence. Factors favoring OPCAB included patients with suitable
anatomy, epicardial target vessels 1 mm or larger, which were
noncalcified and easy to expose, patients considered at high risk
for CPB, elderly patients with multiple preoperative morbidities,
and especially patients with significant calcification of the ascend-
ing aorta and vascular disease.
Contraindications to OPCAB included technical issues such as
small, calcified, intramyocardial coronary targets. Difficulty in
vessel exposure and unstable condition of the patient also pre-
cluded an off-pump approach.
Four hospitals were used by the group with 90% of all cases at
Cedars-Sinai Medical Center.
Surgical Technique
OPCAB. A median sternotomy or small anterior thoracotomy
(minimally invasive direct coronary artery bypass, MIDCAB) was
used. For the small anterior thoracotomy, internal thoracic artery
(ITA) harvest was with one of two specialized retractors (LIMA
lift; Cardiothoracic Systems, Inc, Cupertino, Calif, or Thoralift,
United States Surgical Corp, Norwalk, Conn). Proximal and distal
coronary artery flow was controlled with silicone rubber loops
(Retract-O-Tape; Quest, Allen, Tex). Blood was cleared from the
anastomotic site with a commercial carbon dioxide saline-blower
(Clearview blower/mister kit; Medtronic, Inc, Minneapolis, Minn).
Commercial stabilizers included suction stabilizers (Medtronic
Octopus I and II; Medtronic, Inc) and U-shaped foot stabilizers
(Universal Stabilizer System; Estech Systems, Inc, Danville, Cal-
if). A heparin dose of 10,000 units was given before vessel
occlusion, and the activated clotting time (ACT) was maintained at
twice control ACT. Heparin was fully reversed before sternal
closure.
We selectively used coronary shunts (Flo-Thru intraluminal
shunt; Bio-Vascular, Inc, St Paul, Minn), primarily in constructing
bypass grafts to dominant right coronary arteries. Exposure for
lateral and inferior wall vessels was achieved by a combination of
deep pericardial stitches, an opening of the right side of the
pericardium to the inferior vena cava-right atrial junction, and a
right decubitus Trendelenberg position. Proximal anastomoses
were made to the ascending aorta with the systolic blood pressure
between 70 to 80 mm Hg and a curved vascular clamp. If signif-
icant aortic calcification precluded safe clamp placement, proximal
anastomoses were made to the side of the ITA.
Conventional CABG
CABG was performed through a median sternotomy under mod-
erate hypothermia (28°C-32°C) and CPB support. Single-dose,
antegrade, cold blood cardioplegia was supplemented with cold
continuous retrograde crystalloid cardioplegia and topical iced
slush to protect the myocardium. Proximal anastomoses were
performed during a single period of aortic crossclamping. The
CPB circuit consists of a roller pump (Jostra Bentley Corp, Irvine,
Calif) and membrane oxygenator (Avecor Affinity, Medtronic,
Inc). Both OPCAB and on-pump CABG patients were discharged
receiving either aspirin or warfarin sodium (Coumadin) if their
heart rhythm was atrial fibrillation.
Results
The OPCAB patients were significantly older (70.9  12
years vs 68.1  11 years; P  .001) than on-pump CABG
patients (Table 1). There were more 90-year-old patients (11
vs 5) and a greater percentage of 80-year-old patients
(20.7% vs 11.4%; P  .05) in the OPCAB group. The
OPCAB patients tended to be more urgent in acuity level
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(29.8% vs 21.7%; P .05). Their anginal symptoms tended
to be more severe (Canadian Cardiovascular Society class
III or IV, 63.8% vs 58.8%; P .05). Their overall predicted
risk by the NNE risk model was significantly greater (11.9%
 13% vs 9.2%  10%; P  .001).
This increased predicted risk in OPCAB patients is re-
flected in a comparison of preoperative risk factors (Table
2). Prior carotid endarterectomy (7.5% vs 4%; P  .002),
chronic obstructive pulmonary disease (14.7% vs 11.3%; P
 .05), creatinine concentration more than 2.0 mg/dL (8.6%
vs 5.2%; P  .008), symptoms of congestive heart failure
(17.5% vs 13.7%; P  .05), and peripheral vascular disease
(26.2% vs. 19.7%; P  .003) were all more prevalent in
OPCAB patients. On-pump CABG patients had a higher
incidence of cigarette use (51.6% vs 45.8%; P  .03),
diabetes (31.7% vs 24.7%; P  .006), and previous myo-
cardial infarction (35.9% vs 29.2%; P  .01).
However, on-pump patients differed significantly from
the OPCAB patients in the extent of their preoperative
coronary artery disease (CAD) and the number and location
of coronary arteries bypassed (Tables 3 and 4). On-pump
CABG patients had significantly more triple-vessel CAD
(58% vs 28%; P  .001) and less single-vessel CAD (11%
vs 33%; P  .001). As a result, they received more bypass
grafts (3.3 vs 1.9; P .001), which was consistent in all age
groups. However, LITA and radial artery use was not dif-
ferent, with right internal thoracic artery (RITA) use show-
ing a modest increase (18.3% vs 12.4%; P  .005) in
on-pump CABG patients. There were significant differences
in location of coronary arteries grafted, with circumflex and
posterior descending coronary arteries more commonly
grafted in the on-pump CABG patients.
Revascularization was incomplete significantly more of-
ten in the OPCAB patients than in the on-pump CABG
group (28.5% vs 14.6%; P  .001). Surgical mortality was
2.5% when the revascularization was complete versus 3.0%
when incomplete (P  .5). Postoperative CVA was 2.3%
TABLE 1. Patient clinical characteristics
Characteristic
OPCAB
(n  389)
On-pump
(n  2412) P value
Age (y)
Mean 70.9 12 68.1 11 .001
90 11 (2.9) 5 (0.2)
80-89 81 (20.7) 275 (11.4)
70-79 134 (34.5) 914 (37.9)
60-69 91 (23.3) 673 (27.9)
60 72 (18.6) 545 (22.6)
Male 279 (71.6) 1815 (75.3) .165
LVEF(%) 54 13 53 14 .150
Acuity
Elective 254 (65.4) 1734 (71.9) .005
Urgent 116 (29.8) 523 (21.7)
Emergency 17 (4.3) 142 (5.9)
Angina CCS
I (7.4) (10.2) .002
II (28.9) (31.0)
III (38.4) (27.6)
IV (25.4) (31.2)
NNE risk (%)
Age (y)
Mean 11.9 13 9.2 10 .001
90 31.2 23 21.7 12 NS
80-89 20.3 14 19.8 14 NS
70-79 14.0 13 11.5 9 .004
60-69 6.0 6 6.5 6 NS
60 2.6 3 3.1 4 NS
Variables are expressed as mean  SD or n (%). CCS, Canadian classifi-
cation system; LVEF, left ventricular ejection fraction; NNE, Northern New
England; NS, not significant.
TABLE 2. Preoperative risk factors
Variable OPCAB On-pump P value
Prior surgery 35 (9.0) 284 (11.8) NS
CEA 29 (7.5) 96 (4.0) .002
CVA 41 (10.5) 211 (8.8) NS
Cigarettes 178 (45.8) 1245 (51.6) .03
COPD 57 (14.7) 273 (11.3) .05
DM 96 (24.7) 763 (31.7) .006
HTN 237 (60.9) 1490 (61.8) NS
Creatinine  2.0 mg/dL 31 (8.6) 124 (5.2) .008
PVD 102 (26.2) 474 (19.7) .003
MI 115 (29.2) 865 (35.9) .01
CHF 68 (17.5) 331 (13.7) .05
LVEF  30% 24 (6.8) 196 (8.3) NS
LM (30.0) (28.6) NS
Variables are expressed as n (%). CEA, Carotid endarterectomy; CHF,
congestive heart failure; COPD, chronic obstructive pulmonary disease;
CVA, cerebral vascular accident; DM, diabetes mellitus; HTN, hyperten-
sion; LM, left main coronary; LVEF  30%, left ventricular ejection fraction
less than 30%; MI, myocardial infarction; NS, not significant; PVD, periph-
eral vascular disease.
TABLE 3. Number of distal anastomoses and diseased
vessels
Variable OPCAB On-pump P value
Distal anastomosis (No.)
Age (y)
Mean 1.9 0.8 3.3 0.8 .001
 90 1.2 0.9 2.8 0.4
80-89 2.0 0.7 3.1 0.7
70-79 1.9 0.8 3.3 0.7
60-69 1.9 0.9 3.4 0.9
 60 1.9 0.8 3.4 0.8
Diseased vessels (%)
1 VD 33 11 .001
2 VD 38 31
3 VD 28 58
Incomplete revascularization (%) 28.5 14.6 .001
Variables are expressed as mean SD or n (%). 1 VD, One-vessel disease;
2 VD, two-vessel disease; 3 VD, three-vessel disease.
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versus 2.2% (P  .89) when comparing complete with
incomplete revascularization. Surgical mortality before and
after 1999 was 2.5% versus 2.7% (P  .71). Postoperative
CVA before and after 1999 was 2.3% versus 2.5% (P 
.66).
Increased age, creatinine concentration greater than 2.0
mg/dL, ejection fraction less than 30%, prior CABG, in-
creased New York Heart Association class, acute myocar-
dial infarction, and increased surgical acuity were found to
be independent variables increasing surgical mortality. Dis-
ease of the LAD vessel was found to decrease surgical
mortality. Increased age, surgical acuity, creatinine level
greater than 2.0 mg/dL, and presence of peripheral vascular
disease were found to increase the incidence of postopera-
tive CVA. However CPB did not increase either surgical
mortality or postoperative CVA (Table 6).
There were no significant differences in mortality be-
tween the groups overall or by age in decades (Table 5).
Incidence of stroke, likewise, was not significantly differ-
ent. Of note, there were no strokes in the OPCAB patients
who were octogenarians, but there were 5 in the septuage-
narian group. Neither group, however, was significantly
different from their same-decade on-pump CABG peers. Of
the 12 deaths in the OPCAB group, 5 died of cardiac related
events, including arrhythmias, pump failure, and myocar-
dial infarction. One died of a stroke, 3 died of small bowel
necrosis, and 3 died of sepsis resulting from pneumonia or
intravascular catheters.
New atrial fibrillation, reoperation for bleeding, deep
sternal infection, sepsis, prolonged intubation, and readmis-
sion within 6 weeks were not significantly different between
groups (Table 7). Twelve-hour postoperative blood loss and
any blood product usage were not different. New dialysis
was slightly more prevalent in the OPCAB group, but the
difference was small. Not surprisingly, the percentage of
OPCAB patients with no complications (72%) closely
matched the on-pump CABG patients (70%). Overall post-
operative length of stay was not different between OPCAB
and on-pump CABG patients. However, OPCAB patients
less than 60 years old had a shorter length of stay than
on-pump patients (4.9 2.2 days vs 6.2 4 days; P .02),
and septuagenarians in the on-pump group had a shorter
length of stay than the off-pump group. Note, this is the only
group, when examined by decade, in which the off-pump
patients were at significantly higher risk than the on-pump
patients.
Discussion
Conventional coronary surgery through a median sternot-
omy with CPB support is the standard for myocardial re-
vascularization. Having a clear, still operative field enabled
the widespread adoption of cardiac surgical techniques for
both myocardial revascularization and valvular replacement
and repair under “safe” conditions. However, the introduc-
tion of less invasive catheter-based techniques and the gen-
eral aging of the population has forced cardiac surgeons to
apply cardiac surgical techniques to an increasingly older
and sicker population.4,5
Tuman and associates6 reported that the risk of end-
organ dysfunction in patients having isolated on-pump
CABG increased exponentially with age. Patients 65 years
of age and younger had a low incidence of neurologic
events (1%), but patients older than 75 years had a 9-fold
increase (8.9%). However, cardiac related morbidity, such
as low cardiac output and postoperative myocardial infarc-
tion, was unrelated to advanced age in the stepwise logistic
regression analysis. They forecast that the use of coronary
revascularization techniques without extracorporeal circula-
TABLE 5. Postoperative complications
Variable OPCAB On-pump P value
Surgical mortality
Age (y)
Overall 12 (3.1) 60 (2.5) NS
 90 3 (27.3) 0 (0.0) NS
80-89 6 (7.7) 14 (5.1) NS
70-79 2 (1.5) 22 (2.4) NS
60-69 1 (1.1) 16 (2.4) NS
60 0 (0.0) 7 (1.3) NS
CVA
Age (y)
Overall 7 (1.8) 55 (2.3) NS
 90 1 (9.1) 0 (0.0) NS
80-89 0 (0.0) 7 (2.6) NS
70-79 5 (3.9) 31 (3.4) NS
60-69 1 (1.1) 13 (1.9) NS
60 0 (0.0) 5 (0.9) NS
Variables are expressed as n (%). CVA, Cerebrovascular accident; NS, not
significant.
TABLE 4. Arterial conduits and arteries bypassed
Variable OPCAB On-pump P value
ITA
Overall 368 (94.7) 2303 (95.5) NS
LITA 355 (91.3) 2228 (92.4) NS
RITA 48 (12.4) 441 (18.3) .005
Radial artery 114 (29.2) 760 (31.5) NS
Coronary artery anastomosis
LAD 356 (91.5) 2303 (95.5) .001
Diagonal 80 (20.5) 943 (39.1) .001
PDA 55 (14.1) 1345 (55.8) .001
Circumflex 202 (51.9) 2119 (87.9) .001
RCA 112 (29) 676 (28) NS
Intermediate 15 (4) 376 (16) .001
Variables are expressed as n (%). ITA, Internal thoracic artery; LAD, left
anterior descending; LITA, left internal thoracic artery; NS, not significant;
PDA, posterior descending artery; RCA, right coronary artery; RITA, right
internal thoracic artery.
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tion or aortic crossclamping may decrease the neurologic
risk of CABG.7,8 Several groups in South America and the
United States reported good results with OPCAB in the
early and middle 1990s.9-11 However, it was not until the
introduction of increasingly sophisticated mechanical stabi-
lizers that OPCAB enjoyed a renaissance. Presently, despite
the lack of any long-term, prospectively randomized studies
to prove the benefit of beating-heart surgery, nearly 20% of
patients in the United States are undergoing myocardial
revascularization without CPB support.1 Among cardiac
surgeons, the argument is increasingly not whether patients
should have beating-heart surgery, but why all patients are
not having beating-heart surgery.
Our series of 389 patients represents a selective use of
beating-heart techniques in our cardiac surgical population.
It is a retrospective, nonrandomized experience and in-
cludes all patients having only myocardial revascularization
by our group during a 5-year period. Our beating-heart
surgery patients were significantly older, with a higher
percentage of patients aged 80 years and older than our
on-pump patients. There are 2 comparable series of octoge-
narians having OPCAB. The Washington Hospital Center
experience differs in that they report a total of 71 patients
over a 12-year period from January 1987 to May 1999.12
Thirty-four percent of the patients underwent an anterior
thoracotomy approach to single-vessel off-pump CABG
(MIDCAB). Among our series of 81 octogenarians and 11
nonagenarians, only 2 patients had an anterior thoracotomy
approach. Their operative mortality (6%) and postoperative
length of stay (9  6 days) for octogenarians was similar to
our results (7.7% mortality and 8.6  4.5 days, length of
stay).
A more comparable series is the experience of Ricci and
associates13 in octogenarians. They compared 97 OPCAB
patients with 172 conventional CABG patients from Janu-
ary 1995 to May 1999. They report a variety of surgical
approaches (median sternotomy, left anterior small thora-
cotomy, left posterior thoracotomy, and subxiphoid access),
although they favored median sternotomy to obtain com-
plete myocardial revascularization. Our 81 OPCAB octoge-
narians were compared with 275 octogenarians having con-
ventional on-pump CABG. Average number of bypass
grafts of OPCAB patients between our series and theirs was
similar (2.0 vs 1.8), as was the number having conventional
CABG (3.1 vs 3.3 grafts per patient). Their reported mor-
tality was higher than ours (10.3% vs 7.7%) for OPCAB but
was similar for on-pump CABG (5.2% vs 5.1%). We found
no difference in risk profile between our off-pump and
on-pump octogenarian CABG patients. As in their series,
we report no episode of stroke in our octogenarians. How-
ever, we did not find a significant difference in stroke rate
compared with our conventional CABG patients. This is
due to the low incidence of stroke seen in our on-pump
CABG patients overall (2.3%), and in our on-pump octo-
genarian patients (2.6%). They reported a significant reduc-
tion in stroke rate as their conventional CABG patients had
a stroke rate of 9.3%. They also reviewed angiographic data
to determine the severity and distribution of CAD. They
observed an important trend to more extensive multivessel
involvement in the CPB cohort. They speculate that this
may explain the difference in graft-patient ratio observed
between the CPB cohort (3.3) compared with the off-pump
cohort (1.8). We also found a trend toward significantly
more extensive CAD in our on-pump patients. The presence
of triple-vessel CAD was twice as often seen in the on-
pump group (58%) versus the off-pump group (28%). This
explains the fewer grafts per patient seen in the OPCAB
(2.0) versus on-pump patients (3.1). This is also consistent
with the less frequent lateral and inferior wall bypass grafts
seen in our OPCAB patients when compared with our
on-pump CABG patients.
Arom and colleagues14 also noted this difference of
TABLE 6. Results of logistic regression
Risk factors
Surgical mortality CVA
OR 95% CL P value OR 95% CL P value
Age (continuous) 1.05 (1.03-1.08) .001 1.04 (1.01-1.07) .009
Creatinine  2.0 mg/dL 3.02 (1.56-5.83) .001 2.52 (1.23-5.18) .012
EF  30% 2.18 (1.16-4.09) .015
Prior CABG 2.29 (1.22-4.29) .010
NYHA class 1.27 (1.07-1.51) .006
MI, this 2.2 (1.28-3.79) .005
Surgical acuity 1.98 (1.44-2.72) .001 1.94 (1.41-2.69) .001
Cath LAD 0.36 (0.20-0.65) .001
PVD 2.42 (1.42-4.10) .001
CPB 1.08 (0.54-2.17) .830 1.59 (0.70-3.57) .267
CABG, Coronary artery bypass grafting; Cath LAD, cardiac catheterization, left anterior descending coronary artery disease; CL, confidence limits; CPB,
cardiopulmonary bypass; EF, ejection fraction; MI, this, myocardial infarction, this admission; NYHA class, New York Heart Association classification; OR,
odds ratio; PVD, peripheral vascular disease.
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grafts per patient between OPCAB and on-pump patients.
They reported 2.1 grafts per patient in the OPCAB group
versus 3.2 grafts per patient in the on-pump CABG group.
This difference was magnified in the high-risk subgroup
(1.6 vs 3.1 grafts per patient; P  .001). In short-term
follow-up, there was a trend to increased recurrent angina
and need for reinterventional procedures in the OPCAB
patients.
Gundry and associates15 reported a 7-year follow-up on
a cohort of patients having OPCAB from 1989 to 1990,
before the current era of commercial stabilizers. They noted
twice as many recatheterizations (30% vs 16%) and three
times the reintervention rate (20% vs 7%) when compared
with a group of patients having on-pump CABG. Their
patients in the OPCAB group received fewer grafts (2.4 
0.9 vs 3.2  1.1 vessels per patient) and a much lower
proportion of lateral and inferior wall bypass grafts.
The possibility of incomplete revascularization and early
failure resulting from technical difficulties in constructing
bypass grafts to the lateral or inferior wall must be consid-
ered. Incomplete revascularization was nearly twice as com-
mon in our OPCAB patients (28.5% vs 14.6%). This did not
affect early outcomes. However, we may encounter in-
creased recurrent angina and future interventions on contin-
ued follow-up.
There are several published series addressing arterial
graft patency in OPCAB surgery. They report excellent
short-term patency for arterial grafting to the anterior
wall.16,17 However, angiographic documentation of success-
ful lateral and inferior wall grafting is lacking.
Bhan and coworkers18 reported on 96 OPCAB patients
who underwent coronary angiography before hospital dis-
charge. They found 97.9% patency of their LITA to LAD
grafts, but they found only 81% patency of their saphenous
vein grafts, which were predominantly placed to lateral and
inferior wall bypass targets.
We were expecting to see decreasing morbidity with an
off-pump approach. However, our series is notable for a
lack of significant differences in postoperative outcomes
between OPCAB and on-pump CABG patients. There were
no significant differences in mortality or stroke rate. Blood
product usage and 12-hour blood loss were not significantly
different between on-pump and OPCAB patients, despite
differences noted by other groups of less bleeding and blood
product usage in OPCAB patients.19 Although not followed
in our database, the increased bleeding and blood product
usage in our series may reflect a selection bias to perform
OPCAB on patients we believe have significant bleeding
risk (ie, patients with prior thrombolytic and antiplatelet
inhibitor use). There were significantly more OPCAB pa-
tients with preoperative renal insufficiency. We did not
follow postoperative creatinine in our database. However,
the incidence of new dialysis was greater in the OPCAB
group (2.1% vs 0.9%; P  .04).
Our series is similar to others in comparing treatment
groups retrospectively adjusted for predicted preoperative
risk. However, biases were introduced including less exten-
sive coronary artery disease and fewer bypass grafts in
OPCAB patients. A multivariable logistic regression anal-
ysis was performed to minimize these biases, but we were
unable to demonstrate any negative effect of CPB on short-
term outcomes. Calafiore and associates20 reported a series
of 1843 patients nearly equally divided between OPCAB
and on-pump CABG. They found in a stepwise logistic
regression analysis that CPB was an independent risk factor
for higher mortality (odds ratio, 2.2; P  .0217).
TABLE 7. Postoperative complications
Variable OPCAB On-pump P value
Postop LOS (d)
Age (y)
Overall 7.7 11.0 7.4 7.0 NS
 90 9.6 5.4 10.8 4.7 NS
80-89 8.6 4.5 9.3 7.4 NS
70-79 9.5 7.7 7.8 7.1 .05
60-69 6.2 7.0 7.0 6.4 NS
60 4.9 2.2 6.2 4.4 .02
New dialysis 8 (2.1) 22 (0.9) .04
New atrial fibrillation 80 (20.6) 511 (21.2) NS
Reoperative bleeding 7 (1.8) 56 (2.3) NS
Deep sternal infection 1 (0.3) 14 (0.6) NS
Prolonged intubation 10 (2.6) 84 (3.5) NS
Twelve-hour blood loss (mL) 511 438 503 519 NS
Blood product use (%) 57.8 57.3 NS
Patients with no complications (%) (72) (70) NS
Readmission 6 weeks 49 (12.6) 306 (12.7) NS
Variables are expressed as mean  SD or n (%). LOS, Length of stay; NS, not significant.
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Randomized multi-institution studies seem to be the only
solution to answering the question whether CPB affects
outcomes in coronary revascularization.
Can these make a difference? The Bypass Angioplasty
Revascularization Investigation (BARI) is a prospective,
randomized study comparing balloon angioplasty (PTCA)
with conventional CABG in multivessel coronary artery
patients.18-20 In BARI, they found significant differences in
outcomes for mortality and reintervention rate favoring
conventional CABG for the randomized patient population
with diabetes. However, these favorable differences in out-
comes for conventional CABG patients who had diabetes
disappeared when examining the BARI registry patients
who had PTCA. This is because the registry patients were
not randomized. They were followed by the BARI investi-
gators, and the decision to undergo PTCA versus CABG
was made by the cardiologist. The diabetic registry patients
who underwent PTCA tended to have less extensive CAD
(ie, more double-vessel disease, less left main and triple-
vessel disease) than patients referred for CABG. Moreover,
unfavorable lesions for PTCA tended to be referred for
CABG. It is not hard to imagine that diabetic patients with
subjectively better vascular runoff and distal bypass targets
were more frequently referred for PTCA. BARI warns us
that all nonrandomized comparisons of OPCAB versus on-
pump CABG will have selection biases, particularly in
terms of extent of CAD and quality of distal targets. As we
have seen, this may affect the rate of recurrent angina and
reinterventions in the future.
In conclusion, our prospective, nonrandomized series
comparing OPCAB with on-pump CABG demonstrates that
we can select slightly higher risk patients for OPCAB with
similar outcomes in the short term. However, a randomized,
prospective study with sufficient numbers of elderly, high-
risk patients is needed to answer questions of short- and
long-term benefit.
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Appendix. List and definition of the variables
Preoperative Preoperative
Age Continuous (y)
Age  70 years old Dicotomous/indicator
Sex Dicotomous/indicator
Body surface area Continuous (m2)
Body mass index Continuous (kg/m2)
Chronic obstructive pulmonary disease Dicotomous/indicator
Diabetes mellitus Dicotomous/indicator
Creatinine Continuous
Creatinine  2.0 mg/dL Dicotomous/indicator
Dialysis Dicotomous/indicator
Ejection fraction Continuous
Ejection fraction  30% Dicotomous/indicator
Prior CABG Dicotomous/indicator
Prior PTCA Dicotomous/indicator
Hypertension Dicotomous/indicator
Cholesterol Continuous (mg/dL)
CABG, Coronary artery bypass grafting; CCS, Canadian Cardiovascular Society; NYHA, New York Heart Association; PTCA, Percutaneous transluminal
coronary angioplasty.
Peripheral vascular disease Dicotomous/indicator
Angina (CCS) Quasi-continuous at 5 levels
Congestive heart failure (NYHA) Quasi-continuous at 5 levels
Myocardial infarction Dicotomous/indicator
Acute myocardial infarction Dicotomous/indicator
Surgical acuity Quasi-continuous at 4 levels
Cerebrovascular accident Dicotomous/indicator
Carotid endarterectomy Dicotomous/indicator
Total diseased vessels Quasi-continuous at 4 levels
Circumflex disease Dicotomous/indicator
Left anterior descending disease Dicotomous/indicator
Left main disease Dicotomous/indicator
Right coronary artery disease Dicotomous/indicator
Height Continuous (m)
Weight Continuous (kg)
Cardiopulmonary bypass Dicotomous/indicator
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